What is the Share Price of Strides Pharma Science Ltd?

Strides Pharma Science Ltd share price is ₹1,021.60 As on 27 July, 2024|07:16

Home
>
Share Price
>
Strides Pharma Science Ltd

Strides Pharma Science Ltd

Q: What is the Market Cap of Strides Pharma Science Ltd?

The Market Cap of Strides Pharma Science Ltd is ₹9,390 As on 27 July, 2024|07:16

Q: What is PE Ratio of Strides Pharma Science Ltd?

The P/E ratio of Strides Pharma Science Ltd is 3919 As on 27 July, 2024|07:16

Q: What is PB Ratio of Strides Pharma Science Ltd?

The PB ratio of Strides Pharma Science Ltd is 4.42 As on 27 July, 2024|07:16

₹ 1,021.60 +32.40 (3.28%)
Updated on 27-07-2024 6:56 AM

Stock Rating

Pros 1

Cons 8

Price Performance

Day's Low
₹992.05

Day's High
₹1,032

₹ 1,021.60

52-w low
₹412.1

52-w high
₹1,032

1,021.60

Day's open
₹996.7
Previous close
₹989.200012
VWAP
₹1,020.99
Lower price band
₹817.3
Upper price band
₹1,225.90

Today's Market Action

The last traded share price of Strides Pharma Science Ltd was 1,021.60 up by 3.28% on the NSE. Its last traded stock price on BSE was 1,022 up by 3.52%. The total volume of shares on NSE and BSE combined was 422,690 shares. Its total combined turnover was Rs 43.16 crores.

Medium and Long Term Market Action

Strides Pharma Science Ltd hit a 52-week high of 1,032 on 27-07-2024 and a 52-week low of 412.1 on 18-08-2023. The stock price of Strides Pharma Science Ltd is down by 0% over the last one month. It is up by 131.84% over the last one year. Don't forget to check the full stock price history in the table below.

Fundamentals

Market Cap (Cr): 9390
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About

Data not available.

FAQ's

What is Share Price of Strides Pharma Science Ltd?

What is the Market Cap of Strides Pharma Science Ltd?

What is PE Ratio of Strides Pharma Science Ltd?

What is PB Ratio of Strides Pharma Science Ltd?

What is the CAGR of Strides Pharma Science Ltd?

How to Buy Strides Pharma Science Ltd Share?

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

Pros

Momentum Strength
The stock is currently exhibiting strong momentum, & is showing consistent strong relative strength.

Cons

Low Sustainable RoE
The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
Low Interest Coverage
The company has a very low Interest coverage ratio of 1.81 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
Highly Cyclical Industry
The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
Low Pricing Power & High Competition
The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
Capital Intensive Business
The company operates an extremely capital intensive business with a low Asset turnover ratio of 1.95. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
Poor Working Capital Cycle
The company has a very poor working capital cycle of 209 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
High Promoter Pledge
The company has a relatively high promoter pledge to the extent of 65% of the total company's shareholding which can have a significantly negative impact on stock.
Negative Margin of Safety
The relative margin of safety of investing in the company is low due to a recent sharp run up in stock prices.

Valuation Analysis

Margin of safety
(27/07/2024)

Margin of Safety Index: Moderate

100.00%

100.00% People are bullish about Strides Pharma Science Ltd

0.00%

0.00 % People are bearish about Strides Pharma Science Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %